{"id":20612,"date":"2024-08-27T15:09:49","date_gmt":"2024-08-27T13:09:49","guid":{"rendered":"https:\/\/plnt.nl\/nieuws\/exculture-secures-funding\/"},"modified":"2024-08-27T15:22:19","modified_gmt":"2024-08-27T13:22:19","slug":"exculture-secures-funding","status":"publish","type":"nieuwsberichten","link":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/","title":{"rendered":"ExCulture secures funding"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"20612\" class=\"elementor elementor-20612 elementor-20599\" data-elementor-post-type=\"nieuwsberichten\">\n\t\t\t\t<div class=\"elementor-element elementor-element-da08975 e-flex e-con-boxed e-con e-parent\" data-id=\"da08975\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0f88d65 elementor-widget elementor-widget-text-editor\" data-id=\"0f88d65\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/exculturebiotech.com\/news\/exculture-secures-funding-from-the-dutch-industrial-biotech-seed-fund-managed-by-capricorn-partners-and-ttt-medtech\/\" target=\"_blank\" rel=\"noopener\">PLNT startup ExCulture B.V.<\/a>, which focuses on the development of an animal-free heparin replacement via fermentation, is proud to announce that it has closed its latest round of investment with Capricorn Partners and TTT Medtech. <\/p>\n<p>The investment allows ExCulture to continue comparison studies between porcine heparin and ExCulture&#8217;s heparin substitute according to pharmacopoeia guidelines. This is essential for advancing the regulatory pathway. <\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9e9a05f e-flex e-con-boxed e-con e-parent\" data-id=\"9e9a05f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9e5a5b1 elementor-widget elementor-widget-heading\" data-id=\"9e5a5b1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">New investment round <\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4040901 elementor-widget elementor-widget-text-editor\" data-id=\"4040901\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The investment round was funded by the Dutch Industrial Biotech Seed Fund, managed by Capricorn Partners&#8217; Cleantech Team, and Medtech TTT, a national platform managed by Innovation Industries.<\/p>\n<p>This funding complements funds obtained by ExCulture in 2023 from UNIIQ, Delft Enterprises (Delft University of Technology) and Libertatis Ergo Holding (Leiden University). Each of the existing and new investors brings a broad network and valuable expertise ranging from industrial biotechnology to pharmaceutical development. <\/p>\n<p>With this new funding, ExCulture will:<\/p>\n<ul>\n<li>Improve product development: Continue chemical and biological characterization studies to advance regulatory development and meet market requirements.<\/li>\n<li>Scale up production: Optimize the bioprocess and prepare for pilot scale production.<\/li>\n<li>Expand research: Invest in research and development to explore additional applications of their fermentation platform technology and increase its impact.<\/li>\n<\/ul>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-91928a2 e-flex e-con-boxed e-con e-parent\" data-id=\"91928a2\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d19dde6 elementor-widget elementor-widget-heading\" data-id=\"d19dde6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">ExCulture's mission<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c8d9392 elementor-widget elementor-widget-text-editor\" data-id=\"c8d9392\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Aisling Foley, co-founder and CEO of ExCulture, highlights how the mission of ExCulture&#8217;s newest investors &#8211; to support emerging, innovative technologies &#8211; aligns perfectly with ExCulture&#8217;s ambitions; \u201cHeparin is the most widely used blood thinner in the world, so it&#8217;s surprising that in the 21st century such an essential drug is still produced as a byproduct of pig slaughter. This method of production has led to global shortages since 2017 and has exposed the supply chain to contamination crises in the past. ExCulture&#8217;s goal is to use our new, animal-free bioprocess to produce a safer product through a more sustainable process. Ultimately, we aim to create a more future-proof method of biopharmaceutical production.\u201d<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0fa547b elementor-widget elementor-widget-button\" data-id=\"0fa547b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/exculturebiotech.com\/news\/exculture-secures-funding-from-the-dutch-industrial-biotech-seed-fund-managed-by-capricorn-partners-and-ttt-medtech\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Read the full article on ExCulture's website<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"featured_media":20604,"template":"","class_list":["post-20612","nieuwsberichten","type-nieuwsberichten","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ExCulture secures funding - PLNT<\/title>\n<meta name=\"description\" content=\"ExCulture B.V., a biotechnology startup, receives funding to develop an innovative animal-free heparin replacement via fermentation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ExCulture secures funding - PLNT\" \/>\n<meta property=\"og:description\" content=\"ExCulture B.V., a biotechnology startup, receives funding to develop an innovative animal-free heparin replacement via fermentation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"PLNT\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-27T13:22:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/plnt.nl\/wp-content\/uploads\/2024\/08\/Nieuws-header-website-PLNT-2024-1024x256.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"256\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@PLNT_Leiden\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/exculture-secures-funding\\\/\",\"url\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/exculture-secures-funding\\\/\",\"name\":\"ExCulture secures funding - PLNT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/exculture-secures-funding\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/exculture-secures-funding\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Nieuws-header-website-PLNT-2024.png\",\"datePublished\":\"2024-08-27T13:09:49+00:00\",\"dateModified\":\"2024-08-27T13:22:19+00:00\",\"description\":\"ExCulture B.V., a biotechnology startup, receives funding to develop an innovative animal-free heparin replacement via fermentation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/exculture-secures-funding\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/exculture-secures-funding\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/exculture-secures-funding\\\/#primaryimage\",\"url\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Nieuws-header-website-PLNT-2024.png\",\"contentUrl\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/Nieuws-header-website-PLNT-2024.png\",\"width\":2400,\"height\":600},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/news\\\/exculture-secures-funding\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/plnt.nl\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ExCulture secures funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/plnt.nl\\\/en\\\/\",\"name\":\"PLNT\",\"description\":\"Where innovation meets entrepreneurship.\",\"publisher\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/plnt.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#organization\",\"name\":\"PLNT\",\"url\":\"https:\\\/\\\/plnt.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/PLNT-Logo-Liggend-Zwart.png\",\"contentUrl\":\"https:\\\/\\\/plnt.nl\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/PLNT-Logo-Liggend-Zwart.png\",\"width\":6689,\"height\":4405,\"caption\":\"PLNT\"},\"image\":{\"@id\":\"https:\\\/\\\/plnt.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/PLNT_Leiden\",\"https:\\\/\\\/www.instagram.com\\\/plntleiden\\\/?hl=nl\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/plnt-leiden\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ExCulture secures funding - PLNT","description":"ExCulture B.V., a biotechnology startup, receives funding to develop an innovative animal-free heparin replacement via fermentation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/","og_locale":"en_US","og_type":"article","og_title":"ExCulture secures funding - PLNT","og_description":"ExCulture B.V., a biotechnology startup, receives funding to develop an innovative animal-free heparin replacement via fermentation.","og_url":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/","og_site_name":"PLNT","article_modified_time":"2024-08-27T13:22:19+00:00","og_image":[{"width":1024,"height":256,"url":"https:\/\/plnt.nl\/wp-content\/uploads\/2024\/08\/Nieuws-header-website-PLNT-2024-1024x256.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@PLNT_Leiden","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/","url":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/","name":"ExCulture secures funding - PLNT","isPartOf":{"@id":"https:\/\/plnt.nl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/#primaryimage"},"image":{"@id":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/plnt.nl\/wp-content\/uploads\/2024\/08\/Nieuws-header-website-PLNT-2024.png","datePublished":"2024-08-27T13:09:49+00:00","dateModified":"2024-08-27T13:22:19+00:00","description":"ExCulture B.V., a biotechnology startup, receives funding to develop an innovative animal-free heparin replacement via fermentation.","breadcrumb":{"@id":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/#primaryimage","url":"https:\/\/plnt.nl\/wp-content\/uploads\/2024\/08\/Nieuws-header-website-PLNT-2024.png","contentUrl":"https:\/\/plnt.nl\/wp-content\/uploads\/2024\/08\/Nieuws-header-website-PLNT-2024.png","width":2400,"height":600},{"@type":"BreadcrumbList","@id":"https:\/\/plnt.nl\/en\/news\/exculture-secures-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/plnt.nl\/en\/home\/"},{"@type":"ListItem","position":2,"name":"ExCulture secures funding"}]},{"@type":"WebSite","@id":"https:\/\/plnt.nl\/en\/#website","url":"https:\/\/plnt.nl\/en\/","name":"PLNT","description":"Where innovation meets entrepreneurship.","publisher":{"@id":"https:\/\/plnt.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/plnt.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/plnt.nl\/en\/#organization","name":"PLNT","url":"https:\/\/plnt.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/plnt.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/01\/PLNT-Logo-Liggend-Zwart.png","contentUrl":"https:\/\/plnt.nl\/wp-content\/uploads\/2023\/01\/PLNT-Logo-Liggend-Zwart.png","width":6689,"height":4405,"caption":"PLNT"},"image":{"@id":"https:\/\/plnt.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/PLNT_Leiden","https:\/\/www.instagram.com\/plntleiden\/?hl=nl","https:\/\/www.linkedin.com\/company\/plnt-leiden\/"]}]}},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/nieuwsberichten\/20612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/nieuwsberichten"}],"about":[{"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/types\/nieuwsberichten"}],"version-history":[{"count":1,"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/nieuwsberichten\/20612\/revisions"}],"predecessor-version":[{"id":20613,"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/nieuwsberichten\/20612\/revisions\/20613"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/media\/20604"}],"wp:attachment":[{"href":"https:\/\/plnt.nl\/en\/wp-json\/wp\/v2\/media?parent=20612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}